Dr. Okey C. Nwozo, MD

Dr. Nwozo practices at Precision Medical Clinic Inc in Atlanta, Georgia.

Dr. Nwozo's NPI, 1720043276, was assigned on April 19, 2006. Dr. Nwozo holds Georgia license 047005.

Dr. Nwozo's primary practice is Precision Medical Clinic Inc, at 3069 Amwiler Rd, Atlanta, GA 30360 in Dekalb County. The practice phone is (770) 441-1617.

Dr. Nwozo's primary practice is Precision Medical Clinic Inc in Atlanta, Georgia. The medical group on file is Hospital Physician Services - Southeast Professional Corporation. Dmand AI also links Dr. Nwozo to 6 more medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nwozo practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Nwozo's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Nwozo is licensed in Georgia.

CMS data shows 299 Medicare services from Dr. Nwozo across 3 procedure codes in 2024, for 182 Medicare patients. Medicare paid $23,336 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 182 Medicare patients who saw Dr. Nwozo in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nwozo's median patient age at 39, with 64% women.

In 2024, Dr. Nwozo wrote 351 Medicare Part D claims for 70 patients. 82% of them were for generic drugs. CMS names the drug for 49 of them, across 4 drugs with 11 or more claims each, at $718 in total drug cost. In 2023, CMS named 131 claims across 9 drugs.

Dr. Nwozo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nwozo as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Nwozo from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $144.